So Yeon Kim Profile
So Yeon Kim

@Sokim_33

Followers
202
Following
457
Statuses
25

Thoracic oncology | Phase I @YaleCancer | @MontefioreNYC alum | @TuftsMedicalCtr alum | @Princeton alum

Joined September 2020
Don't wanna be here? Send us removal request.
@Sokim_33
So Yeon Kim
@Sokim_33
29 days
@JacquelyneGMD Feel better soon Jackie! <3
1
0
0
@Sokim_33
So Yeon Kim
@Sokim_33
5 months
RT @rajatthawani: Our attempt at the Ellen ‘Oscar selfie’ at the @JTOonline reviewer workshop before leaving San Diego! Thank you to the fa…
0
3
0
@Sokim_33
So Yeon Kim
@Sokim_33
5 months
@vs_lim @rajatthawani @JTOonline @DrAlexAdjei @KarenReckampMD @oncoOuLungCA @IASLC @LeiDeng3 @c_vakka @IvyLorena_Md Thank you for a wonderful workshop!
0
0
2
@Sokim_33
So Yeon Kim
@Sokim_33
2 years
RT @DrSteveMartin: Data on Dato- encouraging!
0
1
0
@Sokim_33
So Yeon Kim
@Sokim_33
2 years
RT @jsoriamd: The efficacy of #immunotherapy is mainly attributed to reactivation of CD8+ T cells that specifically recognize tumour antige…
0
48
0
@Sokim_33
So Yeon Kim
@Sokim_33
2 years
RT @LMFendo: About last night. A feast! They had to place a small table behind us for additional food plates which didn’t fit on the table.…
0
1
0
@Sokim_33
So Yeon Kim
@Sokim_33
2 years
RT @YaleCancer: An analysis by @Sokim_33 @AminNassarMD & colleagues of treatment options for patients with stage III unresectable EGFR muta…
0
3
0
@Sokim_33
So Yeon Kim
@Sokim_33
2 years
@chulkimMD Congratulations!!
1
0
1
@Sokim_33
So Yeon Kim
@Sokim_33
2 years
RT @DrJNaidoo: #AACR23 Is #AEGEAN a sea change? - Ph III neodj durva+chemo + 1yr durva post surgery v chemo alone in early stage NSCLC - 7…
0
27
0
@Sokim_33
So Yeon Kim
@Sokim_33
2 years
@LeciaSequist Aw, it was so wonderful to meet you! Thank you and very much enjoyed your talk!
0
0
1
@Sokim_33
So Yeon Kim
@Sokim_33
2 years
RT @DrSteveMartin: 2 for the price of..0! Cambridge Press Elements in Molecular Oncology chapters on precision oncology in NSCLC- EGFR + be…
0
6
0
@Sokim_33
So Yeon Kim
@Sokim_33
2 years
RT @YaleCancer: BFAST but be smart! @DrRoyHerbstYale & @Sokim_33 discuss results of a phase III trial evaluating blood-based tumor mutation…
0
4
0
@Sokim_33
So Yeon Kim
@Sokim_33
2 years
Credits to the whole team! @DrSteveMartin @slowwalker919 @StephenVLiu @HaiyingCheng @PatrickCMa1 @chulkimMD @ReckampK @dipeshuprety4 @MNagasaka
@StephenVLiu
Stephen V Liu, MD
@StephenVLiu
2 years
#NACLC22 Dr. @maryjofidlerMD discusses targeted agents for #METex14 NSCLC, highlighting work from Dr. @Sokim_33 in #JTOCRR
Tweet media one
2
1
25
@Sokim_33
So Yeon Kim
@Sokim_33
3 years
@HinaKhanMD Thank you, Dr. Khan!
0
0
0
@Sokim_33
So Yeon Kim
@Sokim_33
3 years
@PatrickCMa1 Yes! For IM residency :)
0
0
1
@Sokim_33
So Yeon Kim
@Sokim_33
3 years
@jmsuga Thank you, Dr. Suga!
0
0
1
@Sokim_33
So Yeon Kim
@Sokim_33
3 years
@PatrickCMa1 Thank you, Dr. Ma!
1
0
1
@Sokim_33
So Yeon Kim
@Sokim_33
3 years
@DrSteveMartin @slowwalker919 @CR_AACR Yay team! Thx Dr. Halmos!
0
0
2
@Sokim_33
So Yeon Kim
@Sokim_33
3 years
RT @StephenVLiu: Extensive characterization of #METex14 NSCLC in #JTOCRR by Drs. @Sokim_33 @DrSteveMartin. Included 21582 samples tested wi…
0
24
0